Latest Biotech News

Bayer AG has entered a global exclusive license and collaboration with Kumquat Biosciences to develop and commercialize Kumquat's KRAS G12D inhibitor, targeting one of the most prevalent oncogenic...

The FDA has approved Insmed’s Brinsupri (brensocatib), the first therapy specifically indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB), a chronic respiratory disease...

Researchers have integrated artificial intelligence into genetic engineering to significantly enhance precision and efficiency. The University of Zurich team developed Pythia, an AI model...

Inspired by insights into ISG15 deficiency, researchers at Columbia University engineered an mRNA-based antiviral showing broad activity against diverse viruses including Zika, SARS-CoV-2, and...

Recent studies have introduced innovative materials and methods enhancing lithium and zinc battery performance. Researchers from Helmholtz-Zentrum Berlin used neutron tomography to clarify...

Multiple pioneering cancer research studies have unveiled promising therapeutic targets and treatment strategies. The University of Pittsburgh identified lncRNA EPIC1 as a driver of immune evasion...

The Biomedical Advanced Research and Development Authority (BARDA) terminated 22 grants supporting mRNA vaccine development, resulting in withdrawal of nearly $500 million in federal funding. This...

Neural organoids are advancing research in human brain development and disease modeling, providing unprecedented biological insight. Researchers at University of California San Diego and the...

Recent clinical trial results and drug approvals are shaping cancer treatment landscapes. Pfizer and Merck's combination therapy of Padcev and Keytruda demonstrated survival improvements in...

Artificial intelligence continues to transform biopharma development and clinical trial operations. 10x Genomics’ acquisition of Scale Biosciences enhances single-cell sequencing capacity and...

Bayer AG has entered a substantial global licensing and collaboration agreement with Kumquat Biosciences to develop and commercialize a KRAS G12D inhibitor, a promising targeted therapy for...

Insmed has achieved a regulatory milestone with the FDA approval of Brinsupri (brensocatib), the first and only treatment specifically approved for non-cystic fibrosis bronchiectasis (NCFB)....

Researchers at the University of Zurich have developed an artificial intelligence-based tool named Pythia to predict DNA repair outcomes following CRISPR/Cas9 editing. This deep learning-assisted...

Recent breakthroughs in immunotherapy focus on overcoming therapeutic resistance and improving treatment efficacy across cancer types. Studies reveal that the long noncoding RNA EPIC1 suppresses...

Scientists from Kyushu University have leveraged ProtGPT2, a protein language model, to generate novel small enzyme variants optimized for bioprocessing applications. This in silico approach...

AbbVie announced a $195 million investment to build a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago. This expansion supports domestic production for...

The integration of artificial intelligence continues to revolutionize biomedical fields. Notable examples include Empatica's compact AI-powered wearable for clinical trial monitoring, tailored to...

Novartis announced back-to-back pivotal phase III successes with its B cell-targeting antibody ianalumab in Sjögren’s syndrome and primary immune thrombocytopenia (ITP), delivering statistically...

Researchers at the University of Maryland School of Medicine have engineered a novel protein therapy that acts as a first-ever antidote for carbon monoxide poisoning. By selectively and rapidly...

Paleoanthropological finds at the Ledi-Geraru site in Ethiopia have uncovered fossil teeth dating between 2.8 and 2.6 million years ago, belonging to a previously unidentified species of...